La compañía biotecnológica estadounidense anunció este lunes que su vacuna contra el coronavirus mostró una eficacia del 94,1%, mientras que la efectividad contra las formas graves de la enfermedad es del 100%.
Los ensayos clínicos de la fase 3 de la vacuna mRNA-1273 incluyeron a 30.000 participantes.
ADVERTISEMENT
459299 666187Your blog is showing a lot more interest and enthusiasm. Thank you so a lot. 459209
Fantastic goods from you, man. I have take into
accout your stuff previous to and you are just extremely great.
I really like what you have got here, really like what you’re stating and
the way by which you assert it. You are making it enjoyable and you continue to care for to
stay it smart. I can’t wait to read far more from you.
This is actually a tremendous web site.
Hey there! This is my first comment here so I just wanted to give a quick shout out and tell you I really enjoy reading your articles.
Can you suggest any other blogs/websites/forums that go over
the same subjects? Appreciate it!